Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amicus, Ascentage, Beyondspring, Cardiff Oncology, Corcept, Experimental Drug Development Centre, Genmab, Ichnos Glenmark, Immuneoncia, Immunitybio, Imunon, Innovent, Jazz, Johnson & Johnson, Kura, Kyowa Kirin, Nasus, OSE, PDS, Perspective, Remegen, Roche, Traws, Vigil Neuroscience.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amber Implants, Freenome, Precede Biosciences, Tactile.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, In8bio, Kalvista, Kymera, Lyra, Nervgen, Novartis, Opus Genetics, Pharvaris, Regeneron, Replimune, Reviva, Teva, Viatris, Vera, Verastem, Xilio.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biolinerx, Corestemchemon, GC Pharma, Immutep, Innovent.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avadel, Biolinerx, Enterome, Faron, GC Biopharma, Genentech, Merck, Pfizer, Regeneron, Roche, Sanofi, Summit.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biohaven, Corestemchemon, Keros, Moderna, Neurocrine, Oric, Pepgen, Taysha, Uniqure.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biohaven, Cumberland, EMD Serono, Evommune, GSK, Inflarx, Irlab, Octapharma, Ono, Spero, Strand, Veru.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Asklepios, Bayer, Bioxcel, Gilgamesh, Immutep, Innovent, Invivyd, Iolyx, Mineralys, Palisade, Rocket.